151 related articles for article (PubMed ID: 23828694)
1. Apoptosis of human pancreatic carcinoma PC-2 cells by an antisense oligonucleotide specific to point mutated K-ras.
Yongxiang W; Liang G; Qinshu S
Pathol Oncol Res; 2014 Jan; 20(1):81-5. PubMed ID: 23828694
[TBL] [Abstract][Full Text] [Related]
2. [The study of the effect of antisense oligonucleotide specific to K-ras point mutation on human pancreatic carcinoma cell PC-2].
Wang YX; Gao L; Ji ZZ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1387-90. PubMed ID: 16318775
[TBL] [Abstract][Full Text] [Related]
3. Inhibitary effects of antisense oligonucleotide specific to K-ras point mutation on the target gene expression in human pancreatic carcinoma cells.
Wang YX; Gao L; Ji ZZ
Chin Med J (Engl); 2007 Aug; 120(16):1448-50. PubMed ID: 17825176
[No Abstract] [Full Text] [Related]
4. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides specific to mutated K-ras genes inhibit invasiveness of human pancreatic cancer cell lines.
Nakada Y; Saito S; Ohzawa K; Morioka CY; Kita K; Minemura M; Takahara T; Watanabe A
Pancreatology; 2001; 1(4):314-9. PubMed ID: 12120210
[TBL] [Abstract][Full Text] [Related]
6. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
Su Z; Lebedeva IV; Gopalkrishnan RV; Goldstein NI; Stein CA; Reed JC; Dent P; Fisher PB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10332-7. PubMed ID: 11526239
[TBL] [Abstract][Full Text] [Related]
7. [Combinational effects of K-ras and IGF-IR antisense oligodeoxynucleotide on proliferation and apoptosis of human pancreatic cancer Patu8988 cells].
Shen YM; Yang XC; Zhang MH; Shen JK; Sun YH
Ai Zheng; 2008 May; 27(5):496-504. PubMed ID: 18479599
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes.
Kita K; Saito S; Morioka CY; Watanabe A
Int J Cancer; 1999 Feb; 80(4):553-8. PubMed ID: 9935156
[TBL] [Abstract][Full Text] [Related]
9. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme as an approach for growth suppression of human pancreatic cancer.
Kijima H; Scanlon KJ
Mol Biotechnol; 2000 Jan; 14(1):59-72. PubMed ID: 10911615
[TBL] [Abstract][Full Text] [Related]
11. Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.
Andreyev HJ; Ross PJ; Cunningham D; Clarke PA
Gut; 2001 Feb; 48(2):230-7. PubMed ID: 11156646
[TBL] [Abstract][Full Text] [Related]
12. Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.
Shen YM; Yang XC; Yang C; Shen JK
World J Gastroenterol; 2008 Sep; 14(33):5176-85. PubMed ID: 18777594
[TBL] [Abstract][Full Text] [Related]
13. Suppression of invasion of a hamster pancreatic cancer cell line by antisense oligonucleotides mutation-matched to K-ras gene.
Morioka CY; Machado MC; Saito S; Nakada Y; Matheus AS; Jukemura J; Bacchella T; Takahara T; Watanabe A
In Vivo; 2005; 19(3):535-8. PubMed ID: 15875772
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo.
Zhu H; Liang ZY; Ren XY; Liu TH
Cancer Biol Ther; 2006 Dec; 5(12):1693-8. PubMed ID: 17106254
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy of pancreatic cancer targeting the K-Ras oncogene.
Lisiansky V; Naumov I; Shapira S; Kazanov D; Starr A; Arber N; Kraus S
Cancer Gene Ther; 2012 Dec; 19(12):862-9. PubMed ID: 23099885
[TBL] [Abstract][Full Text] [Related]
16. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
17. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
Aoki K; Yoshida T; Sugimura T; Terada M
Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
[TBL] [Abstract][Full Text] [Related]
19. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
